Schedule 13G ownership disclosure
CYCLACEL PHARMACEUTICALS INC
Security class unavailable · CUSIP: 23254L603
Event date: 2020-04-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 279,689
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-054110
- Form type
- SC 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Apr 30, 2020
- Reporting period
- Apr 21, 2020
- Description
- Schedule 13G beneficial ownership